Metabolic syndrome influences cardiac gene expression pattern at the transcript level in male ZDF rats

Cardiovascular Diabetology

Volumn 12, Issue 1, 2013, Pages

  Sárközy, Márta ^a   Zvara, Ágnes ^b   Gyémánt, Nóra ^a   Fekete, Veronika ^a   Kocsis, Gabriella F ^a   Pipis, Judit ^a,c   Szucs, Gergo ^a   Csonka, Csaba ^a,c   Puskás, László G ^b   Ferdinandy, Péter ^c,d   Csont, Tamás ^a,c  

^a UNIVERSITY OF SZEGED   (Hungary)

^b INSTITUTE OF BIOCHEMISTRY   (Hungary)

^c PHARMAHUNGARY GROUP   (Hungary)

^d SEMMELWEIS UNIVERSITY   (Hungary)

Author keywords

Diabetes mellitus type 2; DNA microarray; GO analysis; Heart; Hyperlipidemia; Metabolic syndrome; Myocardium

Indexed keywords

3 NITROTYROSINE; ACTIVATING TRANSCRIPTION FACTOR 3; ADENOSINE TRIPHOSPHATASE; AGGRECANASE 1; ARGININOSUCCINATE SYNTHASE; CALCIUM BINDING PROTEIN; CHAPERONIN 60; CHOLESTEROL; GLUCOSE; GLUTATHIONE TRANSFERASE; HEAT SHOCK PROTEIN 70; HYDROXYMETHYLGLUTARYL COENZYME A SYNTHASE; INSULIN; INTERLEUKIN 18; PHOSPHOLIPASE A2; SODIUM POTASSIUM CHLORIDE COTRANSPORTER; TRIACYLGLYCEROL; UBIQUITIN THIOLESTERASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DISEASE COURSE; DNA MICROARRAY; DOWN REGULATION; GENE EXPRESSION PROFILING; GENETIC TRANSCRIPTION; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE; HEART DISEASE; HEART MUSCLE; INSULIN BLOOD LEVEL; INSULIN SENSITIVITY; MALE; METABOLIC SYNDROME X; NITROSATIVE STRESS; NONHUMAN; NUCLEOTIDE SEQUENCE; ORAL GLUCOSE TOLERANCE TEST; OXIDATIVE STRESS; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ISOLATION; SIGNAL TRANSDUCTION; TRIACYLGLYCEROL BLOOD LEVEL; UNINDEXED SEQUENCE; UPREGULATION; ZUCKER DIABETIC FATTY RAT;

ANIMALS; BLOOD GLUCOSE; GENE EXPRESSION REGULATION; MALE; METABOLIC SYNDROME X; MYOCARDIUM; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RATS; RATS, ZUCKER; TRANSCRIPTION, GENETIC;

EID: 84872142020     PISSN: None     EISSN: 14752840     Source Type: Journal    
DOI: 10.1186/1475-2840-12-16     Document Type: Article

References (95)

1. He J, Ogden LG, Bazzano LA, Vupputuri S, Loria C, Whelton PK. Risk factors for congestive heart failure in US men and women: NHANES I epidemiologic follow-up study. Arch Intern Med 2001, 161:996-1002. 10.1001/archinte.161.7.996, 11295963.
2. Lakka HM, Laaksonen DE, Lakka TA, Niskanen LK, Kumpusalo E, Tuomilehto J, Salonen JT. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA 2002, 288:2709-2716. 10.1001/jama.288.21.2709, 12460094.
3. Sattar N, Gaw A, Scherbakova O, Ford I, O'Reilly DS, Haffner SM, Isles C, Macfarlane PW, Packard CJ, Cobbe SM, Shepherd J. Metabolic syndrome with and without C-reactive protein as a predictor of coronary heart disease and diabetes in the West of Scotland Coronary Prevention Study. Circulation 2003, 108:414-419. 10.1161/01.CIR.0000080897.52664.94, 12860911.
4. Malik S, Wong ND, Franklin SS, Kamath TV, L'Italien GJ, Pio JR, Williams GR. Impact of the metabolic syndrome on mortality from coronary heart disease, cardiovascular disease, and all causes in United States adults. Circulation 2004, 110:1245-1250. 10.1161/01.CIR.0000140677.20606.0E, 15326067.
5. Alberti KG, Zimmet P, Shaw J. IDF Epidemiology Task Force Consensus Group: The metabolic syndrome-a new worldwide definition. Lancet 2005, 366:1059-1062. 10.1016/S0140-6736(05)67402-8, 16182882.
6. Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, Fruchart JC, James WP, Loria CM, Smith SC, International Diabetes Federation Task Force on Epidemiology and Prevention, Hational Heart, Lung, and Blood Institute, American Heart Association, World Heart Federation, International Atherosclerosis Society, International Association for the Study of Obesity Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 2009, 120:1640-1645. 10.1161/CIRCULATIONAHA.109.192644, 19805654, International Diabetes Federation Task Force on Epidemiology and Prevention, Hational Heart, Lung, and Blood Institute, American Heart Association, World Heart Federation, International Atherosclerosis Society, International Association for the Study of Obesity.
7. Grundy SM. Pre-diabetes, metabolic syndrome, and cardiovascular risk. J Am Coll Cardiol 2012, 59:635-643. 10.1016/j.jacc.2011.08.080, 22322078.
8. Reaven GM. Insulin resistance, the insulin resistance syndrome, and cardiovascular disease. Panminerva Med 2005, 47:201-210.
9. Aschner P. Metabolic syndrome as a risk factor for diabetes. Expert Rev Cardiovasc Ther 2010, 8:407-412. 10.1586/erc.10.13, 20222818.
10. Mensah GA, Mokdad AH, Ford E, Narayan KM, Giles WH, Vinicor F, Deedwania PC. Obesity, metabolic syndrome, and type 2 diabetes: emerging epidemics and their cardiovascular implications. Cardiol Clin 2004, 22:485-504. 10.1016/j.ccl.2004.06.005, 15501618.
11. Giricz Z, Mentzer RM, Gottlieb RA. Autophagy, myocardial protection, and the metabolic syndrome. J Cardiovasc Pharmacol 2012, 60:125-132. 10.1097/FJC.0b013e318256ce10, 22472909.
12. Ovize M, Baxter GF, Di Lisa F, Ferdinandy P, Garcia-Dorado D, Hausenloy DJ, Heusch G, Vinten-Johansen J, Yellon DM, Schulz R, Working Group of Cellular Biology of Heart of European Society of Cardiology Postconditioning and protection from reperfusion injury: where do we stand? Position paper from the Working Group of Cellular Biology of the Heart of the European Society of Cardiology. Cardiovasc Res 2010, 87:406-423. 10.1093/cvr/cvq129, 20448097, Working Group of Cellular Biology of Heart of European Society of Cardiology.
13. Ferdinandy P, Schulz R, Baxter GF. Interaction of cardiovascular risk factors with myocardial ischemia/reperfusion injury, preconditioning, and postconditioning. Pharmacol Rev 2007, 59:418-458. 10.1124/pr.107.06002, 18048761.
14. Kristiansen SB, Lofgren B, Stottrup NB, Khatir D, Nielsen-Kudsk JE, Nielsen TT, Botker HE, Flyvbjerg A. Ischaemic preconditioning does not protect the heart in obese and lean animal models of type 2 diabetes. Diabetologia 2004, 47:1716-1721. 10.1007/s00125-004-1514-4, 15480537.
15. Ravingerova T, Stetka R, Pancza D, Ulicna O, Ziegelhoffer A, Styk J. Susceptibility to ischemia-induced arrhythmias and the effect of preconditioning in the diabetic rat heart. Physiol Res 2000, 49:607-616.
16. Tosaki A, Pali T, Droy-Lefaix MT. Effects of Ginkgo biloba extract and preconditioning on the diabetic rat myocardium. Diabetologia 1996, 39:1255-1262. 10.1007/s001250050567, 8932989.
17. Tosaki A, Engelman DT, Engelman RM, Das DK. The evolution of diabetic response to ischemia/reperfusion and preconditioning in isolated working rat hearts. Cardiovasc Res 1996, 31:526-536.
18. Przyklenk K, Maynard M, Greiner DL, Whittaker P. Cardioprotection with postconditioning: loss of efficacy in murine models of type-2 and type-1 diabetes. Antioxid Redox Signal 2011, 14:781-790. 10.1089/ars.2010.3343, 3052273, 20578962.
19. Ungi I, Ungi T, Ruzsa Z, Nagy E, Zimmermann Z, Csont T, Ferdinandy P. Hypercholesterolemia attenuates the anti-ischemic effect of preconditioning during coronary angioplasty. Chest 2005, 128:1623-1628. 10.1378/chest.128.3.1623, 16162767.
20. Kupai K, Csonka C, Fekete V, Odendaal L, van Rooyen J, Marais De W, Csont T, Ferdinandy P. Cholesterol diet-induced hyperlipidemia impairs the cardioprotective effect of postconditioning: role of peroxynitrite. Am J Physiol Heart Circ Physiol 2009, 297:H1729-H1735. 10.1152/ajpheart.00484.2009, 19734363.
21. Cameron AJ, Shaw JE, Zimmet PZ. The metabolic syndrome: prevalence in worldwide populations. Endocrinol Metab Clin North Am 2004, 33:351-375. table of contents, 10.1016/j.ecl.2004.03.005, 15158523.
22. Amuna P, Zotor FB. Epidemiological and nutrition transition in developing countries: impact on human health and development. Proc Nutr Soc 2008, 67:82-90. 10.1017/S0029665108006058, 18234135.
23. de Onis M, Blossner M. Prevalence and trends of overweight among preschool children in developing countries. Am J Clin Nutr 2000, 72:1032-1039.
24. Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA 2002, 287:356-359. 10.1001/jama.287.3.356, 11790215.
25. Abdul-Ghani MA, Williams K, DeFronzo RA, Stern M. What is the best predictor of future type 2 diabetes?. Diabetes Care 2007, 30:1544-1548. 10.2337/dc06-1331, 17384342.
26. Suh YH, Kim Y, Bang JH, Choi KS, Lee JW, Kim WH, Oh TJ, An S, Jung MH. Analysis of gene expression profiles in insulin-sensitive tissues from pre-diabetic and diabetic Zucker diabetic fatty rats. J Mol Endocrinol 2005, 34:299-315. 10.1677/jme.1.01679, 15821098.
27. Garnett KE, Chapman P, Chambers JA, Waddell ID, Boam DS. Differential gene expression between Zucker Fatty rats and Zucker Diabetic Fatty rats: a potential role for the immediate-early gene Egr-1 in regulation of beta cell proliferation. J Mol Endocrinol 2005, 35:13-25. 10.1677/jme.1.01792, 16087718.
28. Bray GA. The Zucker-fatty rat: a review. Fed Proc 1977, 36:148-153.
29. Kurtz TW, Morris RC, Pershadsingh HA. The Zucker fatty rat as a genetic model of obesity and hypertension. Hypertension 1989, 13:896-901. 10.1161/01.HYP.13.6.896, 2786848.
30. de Chantemele EJ B, Vessieres E, Guihot AL, Toutain B, Maquignau M, Loufrani L, Henrion D. Type 2 diabetes severely impairs structural and functional adaptation of rat resistance arteries to chronic changes in blood flow. Cardiovasc Res 2009, 81:788-796.
31. Gustavsson C, Soga T, Wahlstrom E, Vesterlund M, Azimi A, Norstedt G, Tollet-Egnell P. Sex-dependent hepatic transcripts and metabolites in the development of glucose intolerance and insulin resistance in Zucker diabetic fatty rats. J Mol Endocrinol 2011, 47:129-143. 10.1530/JME-11-0007, 21673048.
32. Corsetti JP, Sparks JD, Peterson RG, Smith RL, Sparks CE. Effect of dietary fat on the development of non-insulin dependent diabetes mellitus in obese Zucker diabetic fatty male and female rats. Atherosclerosis 2000, 148:231-241. 10.1016/S0021-9150(99)00265-8, 10657558.
33. Leonard BL, Watson RN, Loomes KM, Phillips AR, Cooper GJ. Insulin resistance in the Zucker diabetic fatty rat: a metabolic characterisation of obese and lean phenotypes. Acta Diabetol 2005, 42:162-170. 10.1007/s00592-005-0197-8, 16382303.
34. Peterson RG, Shaw WN, Neel M, Little LA, Eichberg J. Zucker diabetic fatty rat as a model for noninsulindependent diabetes mellitus. ILAR News 1990, 32:16-19.
35. Unger RH, Orci L. Diseases of liporegulation: new perspective on obesity and related disorders. FASEB J 2001, 15:312-321. 10.1096/fj.00-0590, 11156947.
36. Csont T, Balogh G, Csonka C, Boros I, Horvath I, Vigh L, Ferdinandy P. Hyperlipidemia induced by high cholesterol diet inhibits heat shock response in rat hearts. Biochem Biophys Res Commun 2002, 290:1535-1538. 10.1006/bbrc.2002.6377, 11820796.
37. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985, 28:412-419. 10.1007/BF00280883, 3899825.
38. Gayoso-Diz P, Otero-Gonzalez A, Rodriguez-Alvarez MX, Gude F, Cadarso-Suarez C, Garcia F, De Francisco A. Insulin resistance index (HOMA-IR) levels in a general adult population: curves percentile by gender and age. The EPIRCE study. Diabetes Res Clin Pract 2011, 94:146-155. 10.1016/j.diabres.2011.07.015, 21824674.
39. Barr EL, Cameron AJ, Balkau B, Zimmet PZ, Welborn TA, Tonkin AM, Shaw JE. HOMA insulin sensitivity index and the risk of all-cause mortality and cardiovascular disease events in the general population: the Australian Diabetes, Obesity and Lifestyle Study (AusDiab) study. Diabetologia 2010, 53:79-88. 10.1007/s00125-009-1588-0, 19894029.
40. Csont T, Bereczki E, Bencsik P, Fodor G, Gorbe A, Zvara A, Csonka C, Puskas LG, Santha M, Ferdinandy P. Hypercholesterolemia increases myocardial oxidative and nitrosative stress thereby leading to cardiac dysfunction in apoB-100 transgenic mice. Cardiovasc Res 2007, 76:100-109. 10.1016/j.cardiores.2007.06.006, 17658498.
41. Chinen I, Shimabukuro M, Yamakawa K, Higa N, Matsuzaki T, Noguchi K, Ueda S, Sakanashi M, Takasu N. Vascular lipotoxicity: endothelial dysfunction via fatty-acid-induced reactive oxygen species overproduction in obese Zucker diabetic fatty rats. Endocrinology 2007, 148:160-165.
42. Zoja C, Cattaneo S, Fiordaliso F, Lionetti V, Zambelli V, Salio M, Corna D, Pagani C, Rottoli D, Bisighini C, Remuzzi G, Benigni A. Distinct cardiac and renal effects of ETA receptor antagonist and ACE inhibitor in experimental type 2 diabetes. Am J Physiol Renal Physiol 2011, 301:F1114-F1123. 10.1152/ajprenal.00122.2011, 21816757.
43. Virok DP, Kis Z, Szegedi V, Juhasz G, Zvara A, Muller G, Levay G, Harsing LG, Rajko R, Penke B, Janka Z, Janaky T, Puskas LG. Functional changes in transcriptomes of the prefrontal cortex and hippocampus in a mouse model of anxiety. Pharmacol Rep 2011, 63:348-361. 10.1124/pr.109.001933, 21602590.
44. Nagy A, Kenesi E, Rentsendorj O, Molnar A, Szenasi T, Sinko I, Zvara A, Oommen ST, Barta E, Puskas LG, Lefebvre V, Kiss I. Evolutionarily conserved, growth plate zone-specific regulation of the matrilin-1 promoter: L-Sox5/Sox6 and Nfi factors bound near TATA finely tune activation by Sox9. Mol Cell Biol 2011, 31:686-699. 10.1128/MCB.00019-10, 3028657, 21173167.
45. Erdi B, Nagy P, Zvara A, Varga A, Pircs K, Menesi D, Puskas LG, Juhasz G. Loss of the starvation-induced gene Rack1 leads to glycogen deficiency and impaired autophagic responses in Drosophila. Autophagy 2012, 8:1124-1135. 3429548, 22562043.
46. Skov V, Knudsen S, Olesen M, Hansen ML, Rasmussen LM. Global gene expression profiling displays a network of dysregulated genes in non-atherosclerotic arterial tissue from patients with type 2 diabetes. Cardiovasc Diabetol 2012, 11:15. 10.1186/1475-2840-11-15, 3348024, 22340758.
47. Bell RM, Yellon DM. Conditioning the whole heart-not just the cardiomyocyte. J Mol Cell Cardiol 2012, 53:24-32. 10.1016/j.yjmcc.2012.04.001, 22521304.
48. Cury DP, Dias FJ, Sosthenes MC, Dos Santos Haemmerle CA, Ogawa K, Da Silva MC, Mardegan Issa JP, Iyomasa MM, Watanabe IS. Morphometric, quantitative, and three-dimensional analysis of the heart muscle fibers of old rats: Transmission electron microscopy and high-resolution scanning electron microscopy methods. Microsc Res Tech 2012, in press.
49. Kuhlmann J, Neumann-Haefelin C, Belz U, Kalisch J, Juretschke HP, Stein M, Kleinschmidt E, Kramer W, Herling AW. Intramyocellular lipid and insulin resistance: a longitudinal in vivo 1H-spectroscopic study in Zucker diabetic fatty rats. Diabetes 2003, 52:138-144. 10.2337/diabetes.52.1.138, 12502504.
50. Shimamura M, Nakagami H, Shimosato T, Moritani T, Nakagami F, Osako MK, Miyake T, Koriyama H, Shimizu H, Morishita R. Irbesartan improves endothelial dysfunction, abnormal lipid profile, proteinuria and liver dysfunction in Zucker diabetic fatty rats independent of glucose and insulin levels. Exp Ther Med 2011, 2:957-961. 3440832, 22977605.
51. Perez-Martinez P, Garcia-Rios A, Delgado-Lista J, Gjelstad IM, Gibney J, Kiec-Wilk B, Camargo A, Helal O, Karlstrom B, Blaak EE, Hall W, Riserus U, Dembinska-Kiec A, Defoort C, Saris WH, Lovegrove JA, Drevon CA, Roche HM, Lopez-Miranda J. Gene-nutrient interactions on the phosphoenolpyruvate carboxykinase influence insulin sensitivity in metabolic syndrome subjects. Clin Nutr 2012, in press.
52. Fredersdorf S, Endemann DH, Luchner A, Heitzmann D, Ulucan C, Birner C, Schmid P, Stoelcker B, Resch M, Muders F, Riegger GA, Weil J. Increased aldosterone levels in a model of type 2 diabetes mellitus. Exp Clin Endocrinol Diabetes 2009, 117:15-20. 10.1055/s-2008-1073128, 18726873.
53. Leguisamo NM, Lehnen AM, Machado UF, Okamoto MM, Markoski MM, Pinto GH, Schaan BD. GLUT4 content decreases along with insulin resistance and high levels of inflammatory markers in rats with metabolic syndrome. Cardiovasc Diabetol 2012, 11:100. 10.1186/1475-2840-11-100, 3439702, 22897936.
54. Fiordaliso F, Leri A, Cesselli D, Limana F, Safai B, Nadal-Ginard B, Anversa P, Kajstura J. Hyperglycemia activates p53 and p53-regulated genes leading to myocyte cell death. Diabetes 2001, 50:2363-2375. 10.2337/diabetes.50.10.2363, 11574421.
55. Laakso M. Hyperglycemia and cardiovascular disease in type 2 diabetes. Diabetes 1999, 48:937-942. 10.2337/diabetes.48.5.937, 10331395.
56. Uehata M, Ishizaki T, Satoh H, Ono T, Kawahara T, Morishita T, Tamakawa H, Yamagami K, Inui J, Maekawa M, Narumiya S. Calcium sensitization of smooth muscle mediated by a Rho-associated protein kinase in hypertension. Nature 1997, 389:990-994. 10.1038/40187, 9353125.
57. Ishiko K, Sakoda T, Akagami T, Naka T, Doi T, Tsujino T, Masuyama T, Ohyanagi M. Hyperglycemia induced cell growth and gene expression via the serum response element through RhoA and Rho-kinase in vascular smooth muscle cells. Prep Biochem Biotechnol 2010, 40:139-151. 10.1080/10826060903558927, 20213575.
58. Kovacs P, Szilvassy Z, Hegyi P, Nemeth J, Ferdinandy P, Tosaki A. Effect of transdermal nitroglycerin on glucose-stimulated insulin release in healthy male volunteers. Eur J Clin Invest 2000, 30:41-44. 10.1046/j.1365-2362.2000.00588.x, 10620000.
59. Toblli J, Cao G, Rivas C, Munoz M, Giani J, Dominici F, Angerosa M. Cardiovascular protective effects of nebivolol in Zucker diabetic fatty rats. J Hypertens 2010, 28:1007-1019. 10.1097/HJH.0b013e328337598c, 20411618.
60. van Zwieten PA. Diabetes and hypertension: experimental models for pharmacological studies. Clin Exp Hypertens 1999, 21:1-16. 10.3109/10641969909068644, 10052637.
61. Cosson E, Valensi P, Laude D, Mesangeau D, Dabire H. Arterial stiffness and the autonomic nervous system during the development of Zucker diabetic fatty rats. Diabetes Metab 2009, 35:364-370. 10.1016/j.diabet.2009.02.007, 19648048.
62. Grinblat L, Pacheco Bolanos LF, Stoppani AO. Decreased rate of ketone-body oxidation and decreased activity of D-3-hydroxybutyrate dehydrogenase and succinyl-CoA:3-oxo-acid CoA-transferase in heart mitochondria of diabetic rats. Biochem J 1986, 240:49-56. 1147374, 3548709.
63. Durgan DJ, Smith JK, Hotze MA, Egbejimi O, Cuthbert KD, Zaha VG, Dyck JR, Abel ED, Young ME. Distinct transcriptional regulation of long-chain acyl-CoA synthetase isoforms and cytosolic thioesterase 1 in the rodent heart by fatty acids and insulin. Am J Physiol Heart Circ Physiol 2006, 290:H2480-H2497. 10.1152/ajpheart.01344.2005, 16428347.
64. Onody A, Csonka C, Giricz Z, Ferdinandy P. Hyperlipidemia induced by a cholesterol-rich diet leads to enhanced peroxynitrite formation in rat hearts. Cardiovasc Res 2003, 58:663-670. 10.1016/S0008-6363(03)00330-4, 12798440.
65. Escobales N, Crespo MJ. Oxidative-nitrosative stress in hypertension. Curr Vasc Pharmacol 2005, 3:231-246. 10.2174/1570161054368643, 16026320.
66. Kaneki M, Shimizu N, Yamada D, Chang K. Nitrosative stress and pathogenesis of insulin resistance. Antioxid Redox Signal 2007, 9:319-329. 10.1089/ars.2006.1464, 17184170.
67. Pacher P, Obrosova IG, Mabley JG, Szabo C. Role of nitrosative stress and peroxynitrite in the pathogenesis of diabetic complications. Emerging new therapeutical strategies. Curr Med Chem 2005, 12:267-275. 10.2174/0929867053363207, 2225483, 15723618.
68. Goodwin BL, Pendleton LC, Levy MM, Solomonson LP, Eichler DC. Tumor necrosis factor-alpha reduces argininosuccinate synthase expression and nitric oxide production in aortic endothelial cells. Am J Physiol Heart Circ Physiol 2007, 293:H1115-H1121. 10.1152/ajpheart.01100.2006, 17496212.
69. Goodwin BL, Corbin KD, Pendleton LC, Levy MM, Solomonson LP, Eichler DC. Troglitazone up-regulates vascular endothelial argininosuccinate synthase. Biochem Biophys Res Commun 2008, 370:254-258. 10.1016/j.bbrc.2008.03.089, 18375203.
70. Haines RJ, Corbin KD, Pendleton LC, Meininger CJ, Eichler DC. Insulin transcriptionally regulates argininosuccinate synthase to maintain vascular endothelial function. Biochem Biophys Res Commun 2012, 421:9-14. 10.1016/j.bbrc.2012.03.074, 22452988.
71. Wang Y, Lam KS, Lam JB, Lam MC, Leung PT, Zhou M, Xu A. Overexpression of angiopoietin-like protein 4 alters mitochondria activities and modulates methionine metabolic cycle in the liver tissues of db/db diabetic mice. Mol Endocrinol 2007, 21:972-986.
72. Staiger H, Haas C, Machann J, Werner R, Weisser M, Schick F, Machicao F, Stefan N, Fritsche A, Haring HU. Muscle-derived angiopoietin-like protein 4 is induced by fatty acids via peroxisome proliferator-activated receptor (PPAR)-delta and is of metabolic relevance in humans. Diabetes 2009, 58:579-589. 2646056, 19074989.
73. Yamada T, Ozaki N, Kato Y, Miura Y, Oiso Y. Insulin downregulates angiopoietin-like protein 4 mRNA in 3T3-L1 adipocytes. Biochem Biophys Res Commun 2006, 347:1138-1144. 10.1016/j.bbrc.2006.07.032, 16870142.
74. Misra MK, Sarwat M, Bhakuni P, Tuteja R, Tuteja N. Oxidative stress and ischemic myocardial syndromes. Med Sci Monit 2009, 15:RA209-RA219.
75. Douglas KT. Mechanism of action of glutathione-dependent enzymes. Adv Enzymol Relat Areas Mol Biol 1987, 59:103-167.
76. L'Ecuyer T, Allebban Z, Thomas R, Vander Heide R. Glutathione S-transferase overexpression protects against anthracycline-induced H9C2 cell death. Am J Physiol Heart Circ Physiol 2004, 286:H2057-H2064. 10.1152/ajpheart.00778.2003, 14726301.
77. Puskas LG, Nagy ZB, Giricz Z, Onody A, Csonka C, Kitajka K, Hackler L, Zvara A, Ferdinandy P. Cholesterol diet-induced hyperlipidemia influences gene expression pattern of rat hearts: a DNA microarray study. FEBS Lett 2004, 562:99-104. 10.1016/S0014-5793(04)00189-9, 15044008.
78. Ivanovic-Matic S, Mihailovic M, Dinic S, Martinovic V, Bogojevic D, Grigorov I, Poznanovic G. The absence of cardiomyopathy is accompanied by increased activities of CAT, MnSOD and GST in long-term diabetes in rats. J Physiol Sci 2010, 60:259-266. 10.1007/s12576-010-0093-z, 20422335.
79. Hung J, McQuillan BM, Chapman CM, Thompson PL, Beilby JP. Elevated interleukin-18 levels are associated with the metabolic syndrome independent of obesity and insulin resistance. Arterioscler Thromb Vasc Biol 2005, 25:1268-1273. 10.1161/01.ATV.0000163843.70369.12, 15790931.
80. Okamoto A, Iwamoto Y, Maru Y. Oxidative stress-responsive transcription factor ATF3 potentially mediates diabetic angiopathy. Mol Cell Biol 2006, 26:1087-1097. 10.1128/MCB.26.3.1087-1097.2006, 1347018, 16428460.
81. Allen-Jennings AE, Hartman MG, Kociba GJ, Hai T. The roles of ATF3 in glucose homeostasis. A transgenic mouse model with liver dysfunction and defects in endocrine pancreas. J Biol Chem 2001, 276:29507-29514. 10.1074/jbc.M100986200, 11371557.
82. Kloner RA, Przyklenk K, Whittaker P. Deleterious effects of oxygen radicals in ischemia/reperfusion. Resolved and unresolved issues. Circulation 1989, 80:1115-1127. 10.1161/01.CIR.80.5.1115, 2553296.
83. Hartman MG, Lu D, Kim ML, Kociba GJ, Shukri T, Buteau J, Wang X, Frankel WL, Guttridge D, Prentki M, Grey ST, Ron D, Hai T. Role for activating transcription factor 3 in stress-induced beta-cell apoptosis. Mol Cell Biol 2004, 24:5721-5732. 10.1128/MCB.24.13.5721-5732.2004, 480886, 15199129.
84. Qi L, Saberi M, Zmuda E, Wang Y, Altarejos J, Zhang X, Dentin R, Hedrick S, Bandyopadhyay G, Hai T, Olefsky J, Montminy M. Adipocyte CREB promotes insulin resistance in obesity. Cell Metab 2009, 9:277-286. 10.1016/j.cmet.2009.01.006, 2730923, 19254572.
85. Kim JY, Lee SH, Song EH, Park YM, Lim JY, Kim DJ, Choi KH, Park SI, Gao B, Kim WH. A critical role of STAT1 in streptozotocin-induced diabetic liver injury in mice: controlled by ATF3. Cell Signal 2009, 21:1758-1767. 10.1016/j.cellsig.2009.07.011, 19647793.
86. Kim JY, Song EH, Lee S, Lim JH, Choi JS, Koh IU, Song J, Kim WH. The induction of STAT1 gene by activating transcription factor 3 contributes to pancreatic beta-cell apoptosis and its dysfunction in streptozotocin-treated mice. Cell Signal 2010, 22:1669-1680. 10.1016/j.cellsig.2010.06.007, 20600850.
87. Fevre C, Bellenger S, Pierre AS, Minville M, Bellenger J, Gresti J, Rialland M, Narce M, Tessier C. The metabolic cascade leading to eicosanoid precursors-desaturases, elongases, and phospholipases A2-is altered in Zucker fatty rats. Biochim Biophys Acta 2011, 1811:409-417. 10.1016/j.bbalip.2010.12.004, 21172452.
88. Chahal J, Chen CC, Rane MJ, Moore JP, Barati MT, Song Y, Villafuerte BC. Regulation of insulin-response element binding protein-1 in obesity and diabetes: potential role in impaired insulin-induced gene transcription. Endocrinology 2008, 149:4829-4836. 10.1210/en.2007-1693, 2582919, 18566119.
89. Colomer JM, Mao L, Rockman HA, Means AR. Pressure overload selectively up-regulates Ca2+/calmodulin-dependent protein kinase II in vivo. Mol Endocrinol 2003, 17:183-192. 10.1210/me.2002-0350, 12554746.
90. Chen NH, Wang YL, Ding JH. Increased heart microsomal Na(+) K(+)-transporting ATPase activity by tetrandrine in spontaneously hypertensive rats. Zhongguo Yao Li Xue Bao 1993, 14:320-325.
91. Boot-Handford RP, Tuckwell DS, Plumb DA, Rock CF, Poulsom R. A novel and highly conserved collagen (pro(alpha)1(XXVII)) with a unique expression pattern and unusual molecular characteristics establishes a new clade within the vertebrate fibrillar collagen family. J Biol Chem 2003, 278:31067-31077. 10.1074/jbc.M212889200, 12766169.
92. Omelchenko T. Regulation of collective cell migration by RhoGAP myosin IXA. Small GTPases 2012, 3:213-218. 10.4161/sgtp.20495, 3520884, 22735295.
93. Zhang Y, Resneck WG, Lee PC, Randall WR, Bloch RJ, Ursitti JA. Characterization and expression of a heart-selective alternatively spliced variant of alpha II-spectrin, cardi+, during development in the rat. J Mol Cell Cardiol 2010, 48:1050-1059. 10.1016/j.yjmcc.2010.01.001, 3537504, 20114050.
94. Yurube T, Takada T, Suzuki T, Kakutani K, Maeno K, Doita M, Kurosaka M, Nishida K. Rat tail static compression model mimics extracellular matrix metabolic imbalances of matrix metalloproteinases, aggrecanases, and tissue inhibitors of metalloproteinases in intervertebral disc degeneration. Arthritis Res Ther 2012, 14:R51. 10.1186/ar3764, 3446417, 22394620.
95. Banerjee I, Fuseler JW, Price RL, Borg TK, Baudino TA. Determination of cell types and numbers during cardiac development in the neonatal and adult rat and mouse. Am J Physiol Heart Circ Physiol 2007, 293:H1883-1191. 10.1152/ajpheart.00514.2007, 17604329.